Skip to content
prognos-logo-light Prognos Health
Main Menu
  • Get Started
  • Careers
  • Blog
  • Pharma
    • Pharma Overview
    • Marketing & Brand Teams
    • Business Insights & Analytics
    • Sales Operations
    • Health Economics and Outcome Researchers (HEOR)
  • Payers
    • Payers Overview
    • Risk
    • Care
    • Clinical Quality
  • Providers
    • Providers Overview
  • Platform
    • Platform Overview
    • Platform Features
    • Health Conditions Covered
  • Resources
    • Brochures
    • Case Studies
    • Infographic
    • Videos
    • Webinars
    • White Papers
  • About Us
    • About Us
    • Client Success
    • Our Team & Advisors
    • Events
    • News
    • Careers
    • Blog
  • Contact Us
Home Blog How Lab Data Can Identify Risk Among Medicare Advantage Members

How Lab Data Can Identify Risk Among Medicare Advantage Members

  • January 30, 2019
  • Posted in Identify Risk

This post was last updated on November 27, 2019 at 2:10 pm

Medicare Advantage Member

By Frank Jackson, EVP, Payer Markets

When payers are identifying risk in Medicare, they start with the most easily accessible data: claims. It’s a reasonable place to start — but claims don’t begin to tell the whole story. Claims have just one field — the primary diagnosis code. They don’t record any secondary diagnoses, which may reveal information that could be crucial in determining a patient’s risk. If a Medicare Advantage payer wants to pull a patient’s chart for a clinical review, it can cost as much as $40 per chart, which is more money than most payers are willing to spend.

Lab data, on the other hand, is easy to obtain and it can provide telling insights on risk. As health technology has advanced and lab testing has become more accurate, lab tests have identified more and more conditions — most of which are covered by Medicare. Predictive models can use combinations of lab tests to predict which conditions a patient might have, which fully informs the payer to do a more comprehensive chart review.

All this, of course, is part of the complex process of risk-based contracting between providers and payers. Lab data collected by the payer can be used as a risk stratification tool for providers. So, when a provider group doesn’t have all the data it needs, payers can identify those who need the most attention, and providers can call them in to help better manage their disease or condition. This is a win-win for providers and patients, as it improves patients’ health while also inflating quality metrics.

The challenge of using lab data to identify risk is that the purpose of the claim is usually different than the content of the lab result. Results often have abbreviated fields that may be difficult to read, so within the medical records, there is a high degree of sharing. The problem is, there is no standard for sharing data outside the provider context. This is where Prognos can help payers — by doing the heavy lifting to standardize for sharing in other cases.

In other words, Prognos dives deep into the system to find fields of data that providers may have overlooked when determining a patient’s risk for disease. It uses artificial intelligence (AI) to aggregate that data, coming to conclusions based on billions of other data points from millions of other patients.

Not only can AI extract information from lab results that helps providers and payers negotiate risk, but it can also identify risk factors for disease to potentially save a Medicare Advantage patient’s life. Machine-learning models can use lab tests to predict the severity of a patient’s condition, which a payer can then relay to the provider. They can also identify clinical care gaps and be used to actually close those gaps, thereby eliminating the need for a labor-intensive chart review.

Identifying risk is not a simple task — but when you have the right partner that can sift through all the data for you, it becomes much easier to manage.

« Reflections on the PMSA Winter Symposium
Innovative Models for Converting AI Data »

Categories

  • AI
  • Disease Awareness
  • Identify Risk
  • Lab Data
  • Marketing Solutions
  • Risk Adjustment
  • Sales Operations
  • Uncategorized

Archives

Latest Tweets

Prognos HealthFollow

Innovative #healthcare #AI company striving to improve health

Prognos Health
prognosAIPrognos Health@prognosAI·
22h

On #WorldCancerDay our very own, Bill Bowman, Clinical Solutions Architect at Prognos Health, sits down for a Q&A discussing targeted #oncology therapies in our latest feature piece on Factor This.

https://prognoshealth.com/blog/lab-testing-insights-support-targeted-oncology-therapies-in-market/

#BioPharma #LabTesting #PrognosisTransformed

Reply on Twitter 1224727607524175872Retweet on Twitter 12247276075241758721Like on Twitter 12247276075241758721Twitter 1224727607524175872
prognosAIPrognos Health@prognosAI·
3 Feb

Exciting times in #pharma looking at potential #fda drug approvals https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2020?mkt_tok=eyJpIjoiTkRNd1pUTTNPVE00WXpabSIsInQiOiJJVEw0ZSt4QThYdDFPdDBxV3RcL2VMbXpSV0ZseGdPSHl5UWRjXC9ZNkhBODZJN1lOQU1aVmFkRDVYUzQ3UjBTZE9JVmJLenMrU3NyeWx3QmRPbDA1QUZJSmJ4bGVocUtjTlwvdkFPN2FZR0dXd0lOeUYxQzJRUVFISjlhVldKck9WaiJ9&mrkid=88868148

Reply on Twitter 1224378769202458624Retweet on Twitter 12243787692024586242Like on Twitter 12243787692024586241Twitter 1224378769202458624
prognosAIPrognos Health@prognosAI·
2 Feb

Predicting many will call in sick tomorrow with post super bowl-itis. #SuperBowl2020 #ArtificialInteligence

Reply on Twitter 1224010094284886016Retweet on Twitter 12240100942848860161Like on Twitter 12240100942848860161Twitter 1224010094284886016
prognosAIPrognos Health@prognosAI·
25 Jan

#ICYMI We’ve hit a milestone. Our patient registry on the prognosFACTOR™ platform spans over 250 million unique de-identified patients. Let’s improve health together.

#PrognosisTransformed #prognosFACTOR #AI #HealthAnalytics #LabData #Healthcare #LifeScience #Payer #HealthTech

Reply on Twitter 1221083826925064193Retweet on Twitter 1221083826925064193Like on Twitter 12210838269250641935Twitter 1221083826925064193
Retweet on TwitterPrognos Health Retweeted
sundeepbhansundeep bhan@sundeepbhan·
25 Jan

I remember when we started @jmbhan with a few thousand patients and talked about reaching 250 million one day. I guess that day is today. Go team @prognosAI https://twitter.com/prognosAI/status/1220762014114553856

Prognos Health@prognosAI

We’ve hit a milestone. Our patient registry on the prognosFACTOR™ platform spans over 250 million unique de-identified patient records. Let’s improve health together.

#PrognosisTransformed #prognosFACTOR #AI #HealthAnalytics #LabData #Healthcare #Pharma #LifeScience #Payer

Reply on Twitter 1220886290780119042Retweet on Twitter 12208862907801190423Like on Twitter 122088629078011904211Twitter 1220886290780119042
Load More...
  • Pharma
    • Pharma Overview
    • Marketing & Brand Teams
    • Business Insights & Analytics
    • Sales Operations
    • Health Economics and Outcome Researchers (HEOR)
  • Payers
    • Payers Overview
    • Risk
    • Care
    • Clinical Quality
  • Providers
    • Providers Overview
  • Platform
    • Platform Overview
    • Platform Features
    • Health Conditions Covered
  • Resources
    • Brochures
    • Case Studies
    • Infographic
    • Videos
    • Webinars
    • White Papers
  • About Us
    • About Us
    • Client Success
    • Our Team
    • Events
    • News
    • Careers
    • Blog
  • Mailing List
    Join our mailing list
  • LinkedIn
  • Twitter
  • YouTube
  • Terms of Use
  • Privacy Policy
  • Site Map
© Prognos Health, 2020. All Rights Reserved.

Let's improve health together

contact us and discover how.

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. For more details about cookies and their use, please see our Privacy Policy.